Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple? Comment

Roghmann F, Goebell P, Dyrskjot L, Van Rhijn BWG, Kaefferlein HU, Hakenberg O, Stenzl A, Burger M, Pesch B, Benderska-Soeder N, Schmitz-Draeger BJ (2022)

Publication Type: Journal article, Editorial

Publication year: 2022

Journal

Bladder Cancer IOS Press

Book Volume: 8

Pages Range: 1-4

Journal Issue: 1

DOI: 10.3233/BLC-211602

Abstract

Marker research, and in particular urine bladder cancer marker research throughout the past three decades, devours enormous scientific resources in terms of manpower (not to mention time spent on reviewing and editorial efforts) and financial resources, finally generating large numbers of manuscripts without affecting clinical decision making. This is mirrored by the fact that current guidelines do not recommend marker use due to missing level 1 evidence.

Authors with CRIS profile

Peter Goebell Urologische Klinik

Involved external institutions

Aarhus University Hospital / Aarhus Universitetshospital DK Denmark (DK) Eberhard Karls Universität Tübingen DE Germany (DE) Antoni van Leeuwenhoek NL Netherlands (NL) St. Theresien-Krankenhaus Nürnberg DE Germany (DE) Ruhr-Universität Bochum (RUB) DE Germany (DE) Institut für Prävention und Arbeitsmedizin der Deutschen Gesetzlichen Unfallversicherung (IPA) DE Germany (DE) Universität Regensburg DE Germany (DE) Universität Rostock DE Germany (DE)

How to cite

APA:

Roghmann, F., Goebell, P., Dyrskjot, L., Van Rhijn, B.W.G., Kaefferlein, H.U., Hakenberg, O.,... Schmitz-Draeger, B.J. (2022). Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple? Comment. Bladder Cancer, 8(1), 1-4. https://dx.doi.org/10.3233/BLC-211602

MLA:

Roghmann, Florian, et al. "Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple? Comment." Bladder Cancer 8.1 (2022): 1-4.

BibTeX: Download